Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15196533

Download in:

View as

General Info

PMID
15196533